Bivalirudin Versus Enoxaparin in Critically Ill COVID-19 Patients
Conditions: Acute Respiratory Failure; SARS CoV 2 Infection; Anticoagulants Interventions: Drug: Enoxaparin Sodium; Drug: Bivalirudin Sponsor: University Magna Graecia Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 19, 2022 Category: Research Source Type: clinical trials